Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia

Author： Alphs Larry Bossie Cynthia A Fu Dong-Jing Ma Yi-Wen Kern Sliwa Jennifer

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 1029-1042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

By Samtani Mahesh N.

Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. : 585-600

Adis International

Access to resources Recommend Favorite

Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

By Rosa Fernanda

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H. Chouinard G. Margolese H.C.

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Applying Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia to Achieve First Remission

By Liu Chen-Chung Chiang Huey-Ling Wu Szu-Ying

CNS Drugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 257-258

Adis International

Access to resources Recommend Favorite